CHESTERBROOK, Pa. — New research published in two leading diabetes journals demonstrated accuracy and reliability of the OneTouch Verio Flex blood glucose monitoring system, and when the system was used with the OneTouch Reveal mobile app, it was associated with significant improvements in glycemic control.
In a study just published in the Journal of Diabetes Science and Technology, leading experts in self-monitoring of blood glucose found that the "new system showed a high level of measurement accuracy."
Another study published in the August issue of JMIR Diabetes randomly assigned 128 adults with sub-optimally controlled type 1 and type 2 diabetes based on A1C into two groups: One group switched from their current blood glucose monitoring meter to the OneTouch Verio Flex blood glucose monitoring system; the other group switched from their current meter to the OneTouch Verio Flex blood glucose monitoring system combined with the OneTouch Reveal mobile app.
Results suggested improved glycemic control at 12 and 24 weeks in both the meter-only and meter-plus-mobile-app groups compared to baseline. According to the study, 88% of the subjects reported the Color Range Indicator on the OneTouch Verio Flex blood glucose monitoring system together with the OneTouch Reveal mobile app "could help me stay on track between visits to my health care provider." Improvements using the app were greatest in the participants with type 2 diabetes and those who received the highest number of healthcare provider text messages.
"Self-monitoring of blood glucose is still the most accurate, effective and accessible way people with diabetes can track their blood sugars," commented Brian Levy, chief medical officer, LifeScan. "With the OneTouch Verio Flex blood glucose monitoring system, we are proud to offer people with diabetes and their care teams a very accurate system that they know they can trust. Building on that accuracy, we now have our interconnected diabetes management OneTouch Reveal system that changes the way patients see their blood sugar. This enables both patients and physicians to use that information to make meaningful decisions about their diabetes management."